This HTML5 document contains 129 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53956450
rdf:type
wikibase:Item
schema:description
bài báo khoa học artigo científico 1998年学术文章 artículu científicu სამეცნიერო სტატია 1998年學術文章 επιστημονικό άρθρο vitenskapelig artikkel мақолаи илмӣ научни чланак 1998年学术文章 1998年の論文 1998年學術文章 articol științific научна статия article scientifique naučni članak artikulong pang-agham scientific article published in February 1998 article scientific artículo científico publicado en 1998 1998年學術文章 artikel ilmiah artigo científico vitskapeleg artikkel vedecký článok บทความทางวิทยาศาสตร์ 1998年学术文章 artykuł naukowy scientific article published in February 1998 1998年学术文章 مقالة علمية نشرت في فبراير 1998 articolo scientifico wissenschaftlicher Artikel article científic artikull shkencor 1998年學術文章 научни чланак 1998年学术文章 scienca artikolo наукова стаття, опублікована в лютому 1998 ফেব্রুয়ারি ১৯৯৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tudományos cikk 1998 nî lūn-bûn artigo científico tieteellinen artikkeli 1998년 논문 teaduslik artikkel vetenskaplig artikel bilimsel makale 1998年学术文章 מאמר מדעי 1998年學術文章 vědecký článek научная статья videnskabelig artikel wetenschappelijk artikel scientific article published in February 1998
p:P577
wds:Q53956450-9B6A3829-BD61-4359-AB5B-17BCC104C4D5
wdt:P577
1998-02-01T00:00:00Z
p:P2860
wds:Q53956450-A4C7CFA7-AB00-451B-8B03-6E64964875B8 wds:Q53956450-BF524C62-19DA-4212-9897-27C939524863 wds:Q53956450-C2070CC5-0DDE-47AD-BBB8-4109E38CE1F6 wds:Q53956450-DF1DEDA1-EC39-4DA5-919B-0CB5F0EA7CE6 wds:Q53956450-371AD8E8-58C8-4336-A043-AB6DAA47B38C wds:Q53956450-3F313073-7AA0-48B8-B225-931FF8A747AC wds:Q53956450-4838E9F2-F010-4532-9FEF-768CB3372135 wds:Q53956450-4B8B02F0-69F2-4067-9E5E-32C335F88941 wds:Q53956450-562C5844-5FEB-4074-91BB-1574C5F4FDDD wds:Q53956450-59492E16-F91B-47E2-B0B6-120E9E39ADC4 wds:Q53956450-6CD1C443-3E18-4355-ADF2-8F89F898FF66 wds:Q53956450-6CF83DCE-0CA3-46FA-BBCC-983B0574289C wds:Q53956450-905C0F8A-F1C4-4ED9-9F9D-B20508C17345 wds:Q53956450-9246F901-A4A3-455E-86E5-1CEF9366C7B6
wdt:P2860
wd:Q72194201 wd:Q72079674 wd:Q33628571 wd:Q71073942 wd:Q34306880 wd:Q72662544 wd:Q72180177 wd:Q36735101 wd:Q72586547 wd:Q56625839 wd:Q48903552 wd:Q71060526 wd:Q42557365 wd:Q67602597
p:P2093
wds:Q53956450-41E7542E-BB04-4FE6-906B-38902A6A5E4C wds:Q53956450-363C266C-1574-4DDF-B2E0-85FB7803BB7D wds:Q53956450-9FDCEAD7-0733-4E25-813F-22F097A210A1 wds:Q53956450-543DF1E6-A725-4D65-A51F-04B0B18D6526 wds:Q53956450-49B09D49-5E71-49D3-9586-D919A162DB63
wdt:P2093
J J Portal D Cavalcanti A Arzimanoglou F Semah M Baulac
rdfs:label
Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.
skos:prefLabel
Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.
schema:name
Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.
p:P1476
wds:Q53956450-43CB5527-DB2B-4BEA-89F1-D1FAC8E87641
wdt:P1476
Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.
p:P304
wds:Q53956450-44F3C538-C966-45F8-BBD5-44544085BDA0
wdt:P304
55-62
p:P31
wds:Q53956450-A0828171-4B05-4404-9515-C43DD04609C1
wdt:P31
wd:Q13442814
p:P921
wds:Q53956450-84D57179-E350-4931-896A-39DB6B9C830A wds:Q53956450-015DFE5C-A0CA-417B-AFF5-D020C6357D08
wdt:P921
wd:Q410352 wd:Q1145523
p:P698
wds:Q53956450-452AD820-AAF4-41BE-9C4A-A9F72CA6C526
wdtn:P698
n12:9548227
wdt:P698
9548227
p:P1433
wds:Q53956450-888D91C7-FB0F-416B-B6AB-5A8927C681B4
wdt:P1433
wd:Q15753758
p:P433
wds:Q53956450-E58A0BDE-300F-4ADF-819D-33A31814AC4C
p:P478
wds:Q53956450-7A02B687-F8FA-404B-835D-CFFB1ED1FFFF
wdt:P433
1
wdt:P478
7
p:P356
wds:Q53956450-19D786EF-5DAA-47BD-8BF9-B4D22425BE13
wdtn:P356
n10:S1059-1311(98)90009-7
wdt:P356
10.1016/S1059-1311(98)90009-7
p:P5875
wds:Q53956450-79E25ACF-7C0E-48FC-BD75-C41F4A1F9274
wdt:P5875
246211091